Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Alan Boddy"'
1
Physiologically based pharmacokinetic modeling approaches for patients with SARS-CoV-2 infection: a case study with imatinib
Autor: Josephine Anne Adattini, Andrew McLachlan, Alan Boddy, Jeffry Adiwidjaja
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes coronavirus disease 2019 (COVID-19), manifests as mild respiratory symptoms to severe respiratory failure and is associated with inflammation and other physiological
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d85fe51366c301e4ea3743fb70b39b7
https://hdl.handle.net/11541.2/30156
Zobrazit plný text záznamu
2
Clinical pharmacokinetic and in vitro combination studies of nolatrexed dihydrochloride (AG337, ThymitaqTM) and paclitaxel
Autor: Hughes, A. N., Griffin, M. J., Newell, D. R., Calvert, A. H., Johnston, A., Kerr, B., Lee, C., Liang, B., Alan Boddy
Publikováno v: British Journal of Cancer
Scopus-Elsevier
A clinical study of nolatrexed dihydrochloride (AG337, ThymitaqTM) in combination with paclitaxel was performed. The aims were to optimize the schedule of administration and determine any pharmacokinetic (PK) interactions between the two drugs. In vi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4298c24b22ce1c0db6207dd4868dce9e
http://europepmc.org/articles/PMC2363406
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje